Marianne De Backer is Chief Executive Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 625,339 shares of VIR, which is worth approximately $4.73 Million. The most recent transaction as insider was on Jun 12, 2024, when has been sold 53,118 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 625K
0% 3M change
8.48% 12M change
Total Value Held $4.73 Million

Marianne De Backer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
SELL
Other acquisition or disposition
-
53,118 Reduced 7.83%
625,339 Common Stock
Apr 03 2024
SELL
Open market or private sale
$690,532 $9.46 p/Share
72,995 Reduced 9.71%
678,457 Common Stock
Feb 22 2024
BUY
Grant, award, or other acquisition
-
175,000 Added 18.89%
751,452 Common Stock
Apr 03 2023
BUY
Grant, award, or other acquisition
-
576,452 Added 50.0%
576,452 Common Stock

Also insider at

ARWR
ARROWHEAD PHARMACEUTICALS, INC. Healthcare
KRON
Kronos Bio, Inc. Healthcare
MDB

Marianne De Backer

Chief Executive Officer
Pasadena, CA

Track Institutional and Insider Activities on VIR

Follow Vir Biotechnology, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VIR shares.

Notify only if

Insider Trading

Get notified when an Vir Biotechnology, Inc. insider buys or sells VIR shares.

Notify only if

News

Receive news related to Vir Biotechnology, Inc.

Track Activities on VIR